CCL17 and Alzheimer disease: Thymus and activation-regulated chemokine (TARC/CCL17) are a type of C-C chemokine that uses CC chemokine receptor 4 (CCR4) as a receptor, and specifically binds to and induces chemotaxis in Th2 cells and is associated with Th2 cell-mediated inflammatory diseases, such as AD [13].